AN OVERVIEW OF CURRENT PHARMACOTHERAPY IN PERENNIAL RHINITIS

Background: Individuals with rhinitis experience significant morbidity due to their disease. Research and clinical care to reduce this suffering are important. Objective: To review the pharmacological agents that have been developed for the treatment of perennial rhinitis. Method: Literature review of human studies. Results: Medication classes include antihistamines, decongestants anticholinergics, cromolyn sodium, and corticosteroids. These vary in regard to their pharmacology, efficacy, and adverse Conclusion: Carefully chosen pharmacotherapy based on an understanding of the pathophysiology of the disease, knowledge of the potential of medications, and commitment to an ongoing patient/physician education and monitoring prog am can lead to improved well-being for individuals with perennial rhinitis.